MitraClip® Registry
ConditionMitral Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKlinik für Kardiologie, Pneumologie und Angiologie
About this trial
Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
severe mitral regurgitation
percutaneous mitral valve repair (PMVR) with the MitraClip® system
Disqualifiers
< 18 years
Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure
Trial population
Patients undergoing percutaneous mitral valve repair (PMVR) with the MitraClip® system
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Major cardiac adverse events
increase in the 30-day risk of adverse events among patients receiving PMVR
Time frame
30 daysSecondary outcomes
1
Mortality
Proportion of patients who are alive at 1 year after receiving
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Klinik für Kardiologie, Pneumologie und Angiologie
Lead sponsor
Heinrich-Heine University, Duesseldorf
Sponsor institution
Source ClinicalTrials.gov